Mortality predictors after 10 years of dialysis: A prospective study of Japanese hemodialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue 4, 2007, Pages 653-660

  Ajiro, Junya ^a   Alchi, Bassam ^a   Narita, Ichiei ^a   Omori, Kentaro ^a   Kondo, Daisuke ^a   Sakatsume, Minoru ^a   Kazama, Junichiro J ^a   Akazawa, Kohei ^a   Gejyo, Fumitake ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FEMALE; HUMAN; JAPAN; MALE; MIDDLE AGED; MORTALITY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; RISK FACTOR; TIME;

FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; TIME FACTORS;

EID: 34548857661     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03160906     Document Type: Article

References (40)

1. Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimburger O, Lindholm B, Bergstrom J: Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 13[Suppl 1]: S28-S36, 2002
2. Fernandez-Reyes MJ, Alvarez-Ude F, Sanchez R, Mon C, Iglesias P, Diez JJ, Vazquez A: Inflammation and malnutrition as predictors of mortality in patients on hemodialysis. J Nephrol 15: 136-143, 2002
3. Nascimento MM, Pecoits-Filho R, Lindholm B, Riella MC, Stenvinkel P: Inflammation, malnutrition and atherosclerosis in end-stage renal disease: A global perspective. Blood Purif 20: 454-458, 2002
4. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P: "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 54: 561-569, 1998
5. Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LY, Young EW: Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 33: 507-517, 1999
6. Salem M: Hypertension in the hemodialysis population? High time for answers. Am J Kidney Dis 33: 592-594, 1999
7. Stidley CA, Hunt WC, Tentori F, Schmidt D, Rohrscheib M, Paine S, Bedrick EJ, Meyer KB, Johnson HK, Zager PG: Changing relationship of blood pressure with mortality over time among hemodialysis patients. J Am Soc Nephrol 17: 513-520, 2006
8. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001-1006, 1993
9. Shinzato T, Nakai S, Akiba T, Yamazaki C, Sasaki R, Kitaoka T, Kubo K, Shinoda T, Kurokawa K, Marumo F, Sato T, Maeda K: Survival in long-term haemodialysis patients: Results from the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 12: 884-888, 1997
10. Owen WF: Status of hemodialysis adequacy in the United States: Does it account for improved patient survival? Am J Kidney Dis 32[Suppl 4]: S39-S43, 1998
11. Saran R, Canaud BJ, Depner TA, Keen ML, McCullough KP, Marshall MR, Port FK: Dose of dialysis: Key lessons from major observational studies and clinical trials. Am J Kidney Dis 44: 47-53, 2004
12. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
13. Nakai S, Wada A, Kitaoka T, Shinzato T, Nagura Y, Kikuchi K, Masakane I, Shinoda T, Yamazaki C, Sakai R, Marubayashi S, Morita O, Iseki K, Usami T, Kimata N, Suzuki K, Tabei K, Fushimi K, Miwa N, Yauchi M, Wakai K, Akiba T: An overview of regular dialysis treatment in Japan (as of 31 December 2004). Ther Apher Dial 10: 476-497, 2006
14. Goldwasser P, Mittman N, Antignani A, Burrell D, Michel MA, Collier J, Avram MM: Predictors of mortality in hemodialysis patients. J Am Soc Nephrol 3: 1613-1622, 1993
15. De Lima JJ, Sesso R, Abensur H, Lopes HF, Giorgi MC, Krieger EM, Pileggi F: Predictors of mortality in long-term haemodialysis patients with a low prevalence of comorbid conditions. Nephrol Dial Transplant 10: 1708-1713, 1995
16. Hocher B, Ziebig R, Altermann C, Krause R, Asmus G, Richter CM, Slowinski T, Sinha P, Neumayer HH: Different impact of biomarkers as mortality predictors among diabetic and nondiabetic patients undergoing hemodialysis. J Am Soc Nephrol 14: 2329-2337, 2003
17. Pifer TB, McCullough KP, Port FK, Goodkin DA, Maroni BJ, Held PJ, Young EW: Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int 62: 2238-2245, 2002
18. Iseki K, Shinzato T, Nagura Y, Akiba T: Factors influencing long-term survival in patients on chronic dialysis. Clin Exp Nephrol 8: 89-97, 2004
19. Iseki K, Uehara H, Nishime K, Tokuyama K, Yoshihara K, Kinjo K, Shiohira Y, Fukiyama K: Impact of the initial levels of laboratory variables on survival in chronic dialysis patients. Am J Kidney Dis 28: 541-548, 1996
20. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15: 458-482, 1990
21. Depner TA (ed.): Single-Compartment Model, Boston, Kluwer, 1991
22. Depner TA: Hemodialysis adequacy: Basic essentials and practical points for the nephrologist in training. Hemodial Int 9: 241-254, 2005
23. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, Metivier F: Cardiac and arterial interactions in end-stage renal disease. Kidney Int 50: 600-608, 1996
24. Safar ME, London GM, Plante GE: Arterial stiffness and kidney function. Hypertension 43: 163-168, 2004
25. London GM, Guerin AP, Pannier B, Marchais SJ, Safar ME: Large artery structure and function in hypertension and end-stage renal disease. J Hypertens 16: 1931-1938, 1998
26. Mourad JJ, Girerd X, Boutouyrie P, Laurent S, Safar M, London G: Increased stiffness of radial artery wall material in end-stage renal disease. Hypertension 30: 1425-1430, 1997
27. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99: 2434-2439, 1999
28. Klassen PS, Lowrie EG, Reddan DN, DeLong ER, Coladonato JA, Szczech LA, Lazarus JM, Owen WF Jr: Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 287: 1548-1555, 2002
29. Tozawa M, Iseki K, lseki C, Takishita S: Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int 61: 717-726, 2002
30. Amar J, Vernier I, Rossignol E, Bongard V, Arnaud C, Conte JJ, Salvador M, Chamontin B: Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int 57: 2485-2491, 2000
31. Iseki K, Kawazoe N, Fukiyama K: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 44: 115-119, 1993
32. Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ: Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 31: 997-1006, 1998
33. Iseki K, Tozawa M, Yoshi S, Fukiyama K: Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 14: 1956-1960, 1999
34. Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35: 469-476, 2000
35. Wanner C, Metzger T: C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients. Nephrol Dial Transplant 17[Suppl 8]: 29-32, discussion 39-40, 2002
36. Wakugawa Y, Kiyohara Y, Tanizaki Y, Kubo M, Ninomiya T, Hata J, Doi Y, Okubo K, Oishi Y, Shikata K, Yonemoto K, Maebuchi D, Ibayashi S, Iida M: C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population: The Hisayama Study. Stroke 37: 27-32, 2006
37. Held PJ, Port FK, Wolfe RA, Stannard DC, Carroll CE, Daugirdas JT, Bloembergen WE, Greer JW, Hakim RM: The dose of hemodialysis and patient mortality. Kidney Int 50: 550-556, 1996
38. Wolfe RA, Ashby VB, Daugirdas JT, Agodoa LY, Jones CA, Port FK: Body size, dose of hemodialysis, and mortality. Am J Kidney Dis 35: 80-88, 2000
39. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA: Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 13: 1061-1066, 2002
40. Lowrie EG, Chertow GM, Lew NL, Lazarus JM, Owen WF: The urea [clearance × dialysis time] product (Kt) as an outcome-based measure of hemodialysis dose. Kidney Int 56: 729-737, 1999